Alstonine as an Antipsychotic: Effects on Brain Amines and Metabolic Changes
Author Information
Author(s): Linck Viviane M., Herrmann Ana P., Piato Ângelo L., Detanico Bernardo C., Figueiró Micheli, Flório Jorge, Iwu Maurice M., Okunji Christopher O., Leal Mirna B., Elisabetsky Elaine
Primary Institution: Universidade Federal do Rio Grande do Sul
Hypothesis
The study aims to verify the effects of alstonine on brain amines and hormonal and metabolic changes in mice.
Conclusion
Alstonine shows potential as an innovative antipsychotic with a unique neurochemical profile.
Supporting Evidence
- Alstonine increases serotonergic transmission and intraneuronal dopamine catabolism.
- Alstonine does not affect prolactin levels or induce weight gain.
- Alstonine prevents fasting-induced decreases in glucose levels.
Takeaway
Alstonine, a natural compound, might help treat schizophrenia without causing weight gain or high blood sugar, unlike some other medications.
Methodology
The study involved administering alstonine to mice and measuring its effects on brain amines, glucose levels, body weight, and prolactin levels.
Limitations
The study was conducted on mice, and results may not directly translate to humans.
Participant Demographics
Male adult albino mice, aged 2 months.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website